NCT00302510View on ClinicalTrials.gov

Therapeutic Effect of Immunoadsorption for Patients With Lipoprotein Glomerulopathy

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

March 31, 2002

Study Completion Date

August 31, 2003

Conditions
Treatment
Interventions
PROCEDURE

immunoadsorption

immunoadsorption

Trial Locations (1)

210002

Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine, Nanjing

All Listed Sponsors
lead

Nanjing University School of Medicine

OTHER

NCT00302510 - Therapeutic Effect of Immunoadsorption for Patients With Lipoprotein Glomerulopathy | Biotech Hunter | Biotech Hunter